Decrease seen in deaths, hospitalizations due to stroke, heart disease | Study: Use total CVD risk to determine hypertension treatment | Reduced inflammation seen with diet, exercise intervention
Web Version
August 21, 2014
PCNA SmartBrief
News about cardiovascular disease prevention and management

Heart Health News
Decrease seen in deaths, hospitalizations due to stroke, heart disease
A study in the journal Circulation found that hospitalizations and deaths in the U.S. caused by stroke and heart disease decreased in the past decade, and researchers credited effective preventive measures, lifestyle changes and better treatment. "The findings are jaw-dropping. They really show that we have begun to reverse this epidemic of heart disease and stroke," said Yale University's Dr. Harlan Krumholz, the study's lead investigator. HealthDay News (8/18)
Share: LinkedInTwitterFacebookGoogle+Email
Study: Use total CVD risk to determine hypertension treatment
A patient's total cardiovascular disease risk, instead of just blood-pressure readings, should be the determining factor for initial treatment of hypertension, researchers from Uppsala University in Sweden reported in the Lancet. An accompanying editorial said more research is needed because some data in the meta-analysis was a decade old and the studies included only a small number of mildly hypertensive patients. Medscape (free registration) (8/18)
Share: LinkedInTwitterFacebookGoogle+Email
Reduced inflammation seen with diet, exercise intervention
Promoting either diet intervention alone or diet plus exercise may improve inflammation in patients with new-onset type 2 diabetes, according to a study in the Journal of the American Heart Association. Researchers who examined about 600 patients found that those in the intervention cohorts attained significantly lower C-reactive protein and adiponectin levels at six months compared with those who received usual care. MedWire News (U.K.) (8/15)
Share: LinkedInTwitterFacebookGoogle+Email
Other News
Emerging Trends
Mayo Clinic focuses new cholesterol guidance on diet, exercise
A Mayo Clinic task force reviewed scientific evidence on the treatment related to cholesterol and cardiovascular disease. The team recommended exercise and diet for three to six months before re-evaluating and then prescribing statin medication if needed. (8/14)
Share: LinkedInTwitterFacebookGoogle+Email
Cholesterol drug lowers heart risk in diabetes patients
Fenofibrate therapy was associated with a 30% reduced odds of adverse cardiovascular events in at-risk women with type 2 diabetes, data indicated. The cholesterol-lowering drug also led to a 24% decline in heart risk in men with diabetes, researchers wrote in Diabetologia. Healio (free registration)/Endocrine Today (8/18)
Share: LinkedInTwitterFacebookGoogle+Email
Agencies unveil Million Hearts Hypertension Control Challenge
The Million Hearts Hypertension Control Challenge was unveiled by HHS and the CDC on Wednesday to identify providers that are leveraging health IT to boost the heart health and blood pressure control. Submissions should include the prevalence of hypertension in the practice or health system and discuss technology used to improve blood pressure control rates. Each of the 20 winners will receive a cash award amounting to $2,000. Health Data Management (8/20)
Share: LinkedInTwitterFacebookGoogle+Email
Other News
Nursing in the News
Study: Natural light may boost mood, health of nurses
A Cornell University study of nurses in the journal Health Environments Research and Design found that access to natural light may be linked to improvements in mood and health. Nurses whose workstations were exposed to natural light had lower blood pressure than those whose workstations had artificial light. Exposure to natural light was associated with improved moods when dealing with patients and increased communication with colleagues. HealthDay News (8/15)
Share: LinkedInTwitterFacebookGoogle+Email
PCNA Update
PCNA President Barbara Fletcher comments on reductions in heart attack, stroke rates in U.S.
Data published in a recent issue of Circulation shows that rates of U.S. hospitalizations and deaths from heart disease and stroke dropped significantly in the last decade. By the end of 2011, hospitalizations rates dropped 38% for heart attack, 30.5% for heart failure and 33.6% for ischemic stroke. PCNA President Barbara Fletcher's comments on the new data were enthusiastic and optimistic. "This news provides us great momentum to continue moving forward in the fight against the leading killer of both men and women. We at PCNA are committed to supporting the work of nurses and all health professionals working with patients to make and sustain lifestyle changes, adhere to evidence-based treatment regimens, and act as full partners in their own care."
Share: LinkedInTwitterFacebookGoogle+Email
PCNA Fall CE Programs focus on new clinical topics
The PCNA Fall Programs are coming up fast! This year brings brand new topics which include Long-Term Management of the ACS Patient: Focus on Antiplatelet Therapy, Update on the Management of Hyperlipidemia, Familial Hypercholesterolemia: Focus on Homozygous Hypercholesterolemia, SIHD Risk Stratification, SIHD in the Older Adult: Diagnostic and Management Considerations, and Diabetes and Stable Ischemic Heart Disease. These complimentary, half-day programs take place annually in various cities around the country. Find a full list of participating cities and register for one of these exciting programs.
Share: LinkedInTwitterFacebookGoogle+Email
Lead Quote
The winds and the waves are always on the side of the ablest navigators."
-- Edward Gibbon,
British historian
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about PCNA ->Join PCNA | News | Clinical Tools | Conferences & Programs | Contact
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Editor:  Tom Parks
Advertising:  Rebecca Adelson
  P: 202.618.5665

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.®
Privacy policy |  Legal Information